Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke
A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according to a new study published ...
Sep 23, 2022
0
13